AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Vor Biopharma Inc. Director's Dealing 2021

Feb 5, 2021

33479_dirs_2021-02-04_7c410e78-3edc-48e5-ac7f-82931f5684bb.zip

Director's Dealing

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Vor Biopharma Inc. (VOR)
CIK: 0001817229
Period of Report: 2021-02-04

Reporting Person: Patterson Matthew R (Director)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	41196	Direct